Predictors of response to neoadjuvant checkpoint inhibition with chemotherapy in triple-negative breast cancer (TNBC): A meta-analysis of randomized control trials (RCTs)

被引：0
|
作者：
Roy, A. M. [1 ]
Attwood, K. [2 ]
Gandhi, S. [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Med Oncol Hematol, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Biostat, Buffalo, NY USA
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.03.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
158P
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [21] Intrinsic subtype and response to neoadjuvant chemotherapy with carboplatin and docetaxel (TCb) in triple-negative breast cancer (TNBC)
    Echavarria Diaz-Guardamino, I.
    Lopez-Tarruella, S.
    Garcia-Saenz, J. A.
    Gomez Moreno, H.
    Moreno, F.
    Jerez, Y.
    Fuentes, H.
    Marquez-Rodas, I.
    Cebollero, M.
    Del Monte-Millan, M.
    Picornell, A.
    Massarrah, T.
    Barnadas, A.
    Prat, A.
    Ballesteros Garcia, A.
    Colomer Bosch, R.
    Pelaez, B.
    Gonzalez-Rivera, M.
    Perou, C. M.
    Martin, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)
    Lips, Esther H.
    Michaut, Magali
    Mulder, Lennart
    Besselink, Nicolle
    Hoogstraat, Marlous L.
    Koudijs, Marco J.
    Voest, Emile E.
    Bernards, Rene
    Wesseling, Jelle
    Wessels, Lodewyk F. A.
    Rodenhuis, Sjoerd
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [24] Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer A meta-analysis of randomized controlled trials
    Wang, Li-Yang
    Xie, Hua
    Zhou, Hang
    Yao, Wen-Xiu
    Zhao, Xin
    Wang, Yi
    SAUDI MEDICAL JOURNAL, 2017, 38 (01) : 18 - 23
  • [25] Addition of immunotherapy to chemotherapy for metastatic triple-negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
    Huo, Xingfa
    Shen, Guoshuang
    Liu, Zhen
    Liang, Yuhua
    Li, Jinming
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [26] Meta-Analysis of Patients with Triple-Negative Breast Cancer (TNBC) from Three Randomized Trials of First-Line Bevacizumab (BV) and Chemotherapy Treatment for Metastatic Breast Cancer (MBC)
    O'Shaughnessy, J.
    Romieu, G.
    Dieras, V.
    Byrtek, M.
    Duenne, A-A
    Miles, D.
    CANCER RESEARCH, 2010, 70
  • [27] Adjuvant capecitabine for early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Liu, Mei
    Fang, Huiying
    Qian, Shengqiang
    ASIAN JOURNAL OF SURGERY, 2022, 45 (09) : 1748 - 1750
  • [28] Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
    Poggio, F.
    Bruzzone, M.
    Ceppi, M.
    Ponde, N. F.
    La Valle, G.
    Del Mastro, L.
    de Azambuja, E.
    Lambertini, M.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1497 - 1508
  • [29] Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
    Li, Zhen-Yu
    Zhang, Zhen
    Cao, Xiao-Zhong
    Feng, Yun
    Ren, Sha-Sha
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
  • [30] Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis
    Mittal, Niti
    Singh, Surjit
    Mittal, Rakesh
    Kaushal, Jyoti
    Kaushal, Vivek
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1754 - +
12345